Occipital lobe epilepsy secondary to Posterior Reversible Encephalopathy Syndrome (PRES) during a post-partum eclampsia in Mali (West Africa) by unknown
Youssoufa et al. BMC Research Notes 2013, 6:321
http://www.biomedcentral.com/1756-0500/6/321CASE REPORT Open AccessOccipital lobe epilepsy secondary to Posterior
Reversible Encephalopathy Syndrome (PRES)
during a post-partum eclampsia in Mali
(West Africa)
Maïga Youssoufa1, Kuate Tegueu Callixte2* and Napon Christian3Abstract
Background: Eclampsia is known to cause posterior reversible encephalopathy syndrome (PRES) that is often
associated with an extensive neurovascular damage affecting preferably posterior regions, often leading to
reversible cortical blindness. In spite the magnitude of these lesions, post eclamptic symptomatic epilepsy
is rare. We therefore report a case of symptomatic occipital lobe epilepsy secondary to PRES.
Case presentation: A 39-year-old female right handed teacher who presented with headache of progressive
onset, phosphenes, rapid decline of visual acuity to blindness, vomiting, repeated generalized tonic-clonic
seizures followed by altered consciousness and very high blood pressure (HBP) of 240/120 mmHg, all of which
started about 12 hours following a normal delivery. Nine months later, the patient presented with paroxysmal
visual symptoms predominating in the right visual field followed by partial tonic clonic seizures with secondary
generalization and recurrence of partial occipital lobe seizures. The pathophysiologic mechanism of irreversible
tissue damage during PRES syndrome could result from a combination of events including the delay for early
treatment, inadequate antihypertensive drugs that could worsen the brain damage by hypo perfusion,
inadequate or delayed treatment for seizures or status epilepticus.
Conclusion: Despite its high incidence in the third world, eclampsia is not a usual cause of epilepsy. Our case is
the first description of post eclamptic occipital lobe epilepsy in Africa. With this report, we draw practitioners’
attention on this rare complication.
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Eclampsia is one of the complications of high blood pres-
sure associated with pregnancy. It is an acute paroxystic
pathology characterized by seizures and altered mental
status and even coma. It remains a common disease in
sub-Saharan Africa, with an incidence estimated at 8 per
1000 new births with significant maternal and perinatal
complications due to shortcomings in the quality of care
offered to the women with this ailment [1,2]. However,
in developed countries, the incidence of eclampsia is* Correspondence: kuate.callixte@gmail.com
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distribution, and reproduction in any mediumbetween 0.2 and 0.5 per 1000 new births [3-5] and
tends to decrease due to optimized prenatal care [2,4]. In
eclampsia, neurological involvement is the most dreaded
and may consist of a posterior reversible encephalopathy
syndrome (PRES) whose reversibility is not as constant as
in the previously described by Hinchey and collaborators
in 1996 [6].
PRES is characterized clinically by the presence of head-
ache, seizures, loss of consciousness, cortical blindness
in a woman with high blood pressure in the third trimester
of pregnancy, and radiological findings in such patients
are predominantly posterior cerebral edema all of which
are reversible within three months [7].tral Ltd. This is an Open Access article distributed under the terms of the
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coming more and more described with the contribution
of brain magnetic resonance imaging (MRI) or cerebral
computerized tomographic (CT) scan. Given the extensive
brain involvement in PRES and the fact that it has been
described to be reversible, there however can occur some
unusual situations where there is irreversible damage to
the brain, mostly related to inappropriate management
at the acute phase [7]. As such, cases of symptomatic
post-eclamptic or post-PRES epilepsy have been reported
most of which are temporal lobe epilepsies [8,9] which
is paradoxical because in PRES, though the lesions are
found in the posterior cerebral vascular topography during
the acute phase of the disease, symptomatic occipital lobe
epilepsy are rare [8].
We therefore report a case of symptomatic occipital
lobe epilepsy secondary to PRES.Figure 1 Brain Computerized tomography showing two
bilateral hematoma of parieto-occipital region with significant
peripheral oedema.Case presentation
A 39-year-old female right handed teacher who presented
with headache of progressive onset, phosphenes, rapid
decline of visual acuity to blindness, vomiting, repeated
generalized tonic-clonic seizures followed by altered
consciousness and very high blood pressure (HBP) of
240/120, all of which started about 12 hours following
a normal delivery. In her past obstetrical history, she is
a mother of 7 living children with unremarkable events
during her pregnancies except for similar severe headaches
that occurred a few hours following her last delivery of
twins in June 2010. Concerning her recent gestation, it is
worth noting that follow up was irregularly and at the third
trimester, she was diagnosed of moderate proteinuria and
HBP. Hypertensive encephalopathy was presumed. A
computerized tomographic (CT) scan of the brain was
immediately requested which showed bilateral symmetric
occipital hematoma with significant peripheral oedema
(Figure 1). Chest X-ray and electrocardiogram showed no
abnormality. Laboratory work-up among which complete
blood count (CBC), prothrombin time (PT), liver enzymes,
blood urea and creatinine, blood glucose level, serum
electrolytes, Thyroid Stimulating Hormone were unre-
markable. HIV 1&2 serology as well as malaria diagnostic
tests were negative. Her 24 hours proteinuria was 0.4 g.
She was admitted into the intensive care unit (ICU) and
initial treatment comprised IV Nicardipine and magnesium
sulfate. Evolution on this treatment was marked by a
fall in Blood Pressure within 6 hours to 130/90 mmHg,
subsidence of seizures and she was discharged from the
ICU to the ward after 72 hours though on there was
persistence of blindness, mental confusion and tetra-
pyramidal syndrome.
The evolution was favorable with disappearance of head-
ache, seizures, regain of visual acuity and mental status andshe was discharge home 15 days after admission. No con-
trol CT scan was done due to financial constraints.
Nine months later, she presented on the night, flashing
lights, colored and mobile spotlights, more frequent on
the right side of her visual field, followed a few minutes
later by a brief loss of consciousness and a secondary
generalization with 3 episodes of tonic clonic seizures in
one night. Ophthalmologic examination was reportedly
normal. Due to the recurrence of partial occipital lobe
seizures with secondary generalization few days later
with the frequency of 2 to 3 seizures per week she was
transferred to the neurology unit of the hospital.
On examination her blood pressure was 120/80 mm
Hg with regular pulse at 65 beats per minute and a
respiratory rate of 22 regular cycles per minute. Heart,
pulmonary and abdominal examination showed no clinical
abnormality and neurological examination was unre-
markable. Lumbar puncture for cerebrospinal fluid analysis
(CSF) was done and it showed no abnormality. Proteinuria
and other biological tests like complete blood count,
prothrombin time, liver enzymes, blood urea and creatin-
ine, blood glucose level, serum electrolytes were normal.
A CT scan was done (about 10 months after the first one)
and it showed total regression of hematoma but marked
bilateral posterior cortical atrophy predominantly on
the right (Figure 2). An electroencephalogram (EEG) was
performed immediately after a seizure and it showed
generalized slow waves and spikes and a diagnosis of
Figure 2 Brain CT-scan (March 2011): cerebral atrophy of the
right posterior region.
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placed on Carbamazepine 200 mg twice a day and after
six months of treatment, the patient became seizure
free and was able to resume her work.
Discussion
The rationale behind our reporting this case lies in the
sequence and unusual nature of events whereby clinically,
at the beginning of Posterior Reversible Encephalopathy
Syndrome (PRES) there is cortical blindness, radiological
finding of bilateral occipital hematoma at the acute phase
then its evolution to cortical atrophy in the chronic phase
and subsequently the occurrence of late symptomatic
occipital lobe epilepsy secondary to vascular sequelae.
Despite the high incidence of eclampsia in Africa [2], we
did not find in the literature any reference on symptomatic
occipital lobe epilepsy secondary to this disease which
is well described in our context.
In this case, evidence for a PRES were: postpartum
eclampsia with encephalopathy and seizures, occipital
localization of the lesions on CT-scan and reversibility
of the disorders [6,10].
Cortical blindness presented by our patient has been
reported in the literature. Cunningham and collaborators
have reported 15 women with a reversible cortical blind-
ness related to eclampsia during 14 years [11], and inthe series by Hinchey and collaborators, out of 15 women,
3 had eclampsia, and 9 patients had visual disturbances
[6]. It is unusual that this blindness has an excellent
prognosis, with full recovery of visual acuity. From a
pathophysiology perspective, the blindness is linked to
vasogenic edema and not vasospasm and so its revers-
ibility is linked to the resolution of edema [12].
The occipital lobe epilepsy secondary to eclampsia that
we found is exceptional. Till date, two patients with
occipital lobe epilepsy post eclampsia have been reported
[8] but contrary to our observation, initial brain CT
imaging was normal in these two patients as reported
by Plazzi and collaborators [8].
The pathophysiologic mechanism of irreversible tissue
damage during PRES syndrome is not clear in the litera-
ture. The irreversible damage that we found in our patient
could result from a combination of events including: delay
in early treatment, inadequate anti-hypertensive drugs
that could worsen the brain damage by hypoperfusion,
inadequate or delayed treatment for seizures or status
epilepticus [7,8,13,14].
The anticonvulsant treatment of choice for the man-
agement of PRES secondary to eclampsia, is magnesium
sulfate. Indeed, a multicenter trial [15], including 1680
eclamptic patients showed clearly the superiority of mag-
nesium sulfate compared to diazepam and phenytoin in
the prevention of seizures. In addition, its anti-edematous
effect, higher than that of mannitol during PRES is known
[16]. Also, a rapid decrease in serum magnesium seems to
contemporarily trigger PRES. In the absence of controlled
trial, treatment with magnesium sulfate is still elective and
in the course of this treatment serum monitoring should
be systematically done in cases of PRES. However, the
effectiveness of magnesium sulfate in preventing eclampsia
in patients with preeclampsia remains controversial [17].
The use of magnesium sulfate, however, raises the
problem of the choice of antihypertensive drugs. Their
association with injectable calcium channel blockers,
generally accepted as the treatment of choice for the
management of high blood pressure at the acute phase
of stroke [18], involves a risk of aggravation: the effect
of calcium channel blockers may be potentiated by mag-
nesium sulfate, then causing a drop in blood pressure with
an increase risk of acute brain damage thus, a risk of irre-
versible sequelae [8,17].
In this case report, an analysis of different stages of the
management shows a significant drop in blood pressure
(BP) during the acute phase. Indeed, the association of
maximum doses of magnesium sulfate and nicardipine
resulted in a sharp fall in BP to less than 50% the original
figures in less than 6 hours. This potentially damaging
attitude is known to aggravate brain lesions, with onset
of irreversible damage which potentially could be epi-
leptogenic [7,8,17].
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causes reversible damage. However, patient care is not
accurate (delayed diagnosis, inappropriate management
of BP and or seizures), irreversible sequelae may alter
the course of the disease.
The relationship between hypertensive encephalopathy,
PRES and symptomatic epilepsy must be confirmed by
longitudinal studies [7].
Conclusion
Eclampsia is still common in developing countries, despite
improvement in the management of pregnancy in many
countries. This condition may be responsible for PRES,
inducing neurovascular lesions typically reversible but
delayed diagnosis and/or inadequate management at the
initial phase can induce irreversible neurological sequelae
which could be potentially epileptogenic. Therefore clini-
cians’ awareness to possible occurrence of symptomatic
occipital lobe epilepsy as sequelae is important. The early
diagnosis of PRES as well as optimal management of its
acute phase is sine qua non to its reversibility.
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